These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18174198)

  • 1. The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer.
    Youssef S; Hachem R; Chemaly RF; Adachi J; Ying J; Rolston K; Raad I
    J Antimicrob Chemother; 2008 Feb; 61(2):421-4. PubMed ID: 18174198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6.
    Spellberg B; Yoo T; Bayer AS
    J Antimicrob Chemother; 2004 Oct; 54(4):832-5. PubMed ID: 15317746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
    Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
    Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study.
    Senneville E; Legout L; Valette M; Yazdanpanah Y; Giraud F; Beltrand E; Obert G; Dubreuil L; Migaud H; Mouton Y
    J Antimicrob Chemother; 2004 Oct; 54(4):798-802. PubMed ID: 15329363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.
    Rao N; Ziran BH; Wagener MM; Santa ER; Yu VL
    Clin Infect Dis; 2004 Apr; 38(8):1058-64. PubMed ID: 15095207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid for the treatment of multidrug-resistant tuberculosis.
    Fortún J; Martín-Dávila P; Navas E; Pérez-Elías MJ; Cobo J; Tato M; De la Pedrosa EG; Gómez-Mampaso E; Moreno S
    J Antimicrob Chemother; 2005 Jul; 56(1):180-5. PubMed ID: 15911549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.
    Gordi T; Tan LH; Hong C; Hopkins NJ; Francom SF; Slatter JG; Antal EJ
    J Clin Pharmacol; 2003 Oct; 43(10):1161-7. PubMed ID: 14517199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.
    Wu VC; Wang YT; Wang CY; Tsai IJ; Wu KD; Hwang JJ; Hsueh PR
    Clin Infect Dis; 2006 Jan; 42(1):66-72. PubMed ID: 16323094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
    Wilcox MH; Tack KJ; Bouza E; Herr DL; Ruf BR; Ijzerman MM; Croos-Dabrera RV; Kunkel MJ; Knirsch C
    Clin Infect Dis; 2009 Jan; 48(2):203-12. PubMed ID: 19072714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS
    J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases.
    Ferry T; Ponceau B; Simon M; Issartel B; Petiot P; Boibieux A; Biron F; Chidiac C; Peyramond D
    Infection; 2005 Jun; 33(3):151-4. PubMed ID: 15940417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sideroblastic anemia after prolonged linezolid therapy].
    Kakimoto T; Nakazato T; Miura R; Kurai H; Yamashita D; Sagara Y; Ishida A
    Rinsho Ketsueki; 2008 Nov; 49(11):1566-8. PubMed ID: 19047790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation.
    Cohen N; Mihu CN; Seo SK; Chung D; Chou J; Heller G; Papanicolaou GA
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1337-41. PubMed ID: 19747643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency.
    Lin YH; Wu VC; Tsai IJ; Ho YL; Hwang JJ; Tsau YK; Wu CY; Wu KD; Hsueh PR
    Int J Antimicrob Agents; 2006 Oct; 28(4):345-51. PubMed ID: 16935472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case report: severe thrombocytopenia].
    Sakka SG; Schürmann A; Knüttgen D; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Apr; 44(4):242-5. PubMed ID: 19367527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid-related pancytopenia in organ-transplant patients: report of two cases.
    Faguer S; Kamar N; Fillola G; Guitard J; Rostaing L
    Infection; 2007 Jun; 35(4):275-7. PubMed ID: 17653505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience of linezolid in bone marrow transplantation patients.
    Hogan HL; Hachem RY; Neuhauser M; Raad II; Coyle E
    J Pharm Pract; 2010 Aug; 23(4):352-7. PubMed ID: 21507835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin toxicity associated with concomitant use of linezolid.
    Bergeron L; Boulé M; Perreault S
    Ann Pharmacother; 2005 May; 39(5):956-61. PubMed ID: 15827071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematological safety of long-term therapy with linezolid.
    Garazzino S; De Rosa FG; Bargiacchi O; Audagnotto S; Maiello A; Di Perri G
    Int J Antimicrob Agents; 2007 Apr; 29(4):480-3. PubMed ID: 17317112
    [No Abstract]   [Full Text] [Related]  

  • 20. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment.
    Plachouras D; Giannitsioti E; Athanassia S; Kontopidou F; Papadopoulos A; Kanellakopoulou K; Giamarellou H
    Clin Infect Dis; 2006 Nov; 43(9):e89-91. PubMed ID: 17029128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.